Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Neurofascin as a novel target for autoantibody-mediated axonal injury
2007
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
Complement-Mediated Acute Effects of Liposome-Encapsulated Hemoglobin
1999
Phase 2 Trial of Vaccination With Tyrosinase Peptides and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma
2000
Plasma Exchange in Neuroimmunological Disorders
2006
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin
1999
Manipulating the Immune System with Immune Globulin
1992
The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action
1988
Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women
1989
Determinants of Mortality and Multiorgan Dysfunction in Cardiac Surgery Patients Requiring Prolonged Mechanical Ventilation
1995
Guillain-Barré syndrome
2016 Standout
Drug-Induced Thrombocytopenia
2007
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Guillain–Barré Syndrome
2012 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase
2007
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura
2000
Drug-Induced Immune Thrombocytopenia
2007
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D
1992
Response to therapy in 37 patients with HIV‐related thrombocytopenic purpura
1987
Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement
1990
Fcγ receptors as regulators of immune responses
2007 Standout
Multiple sclerosis
2008 Standout
Myasthenia Gravis
1994 Standout
High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia
1988
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Cytotoxic antibodies trigger inflammation through Fc receptors
1995
Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti‐D immunoglobulins
1994
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
1994
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application
2010
Graft-versus-host disease
2009 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Oxidative Stress in Cancer
2020 Standout
Fc receptor blockade and immune thrombocytopenic purpura
2000
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
1993
Flavonoid intake and risk of chronic diseases
2002 Standout
Danazol for Children With Immune Thrombocytopenic Purpura
1988
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
1987 StandoutNature
Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management
2007
Immune thrombocytopenic purpura in adults
2007
FcRn: the neonatal Fc receptor comes of age
2007 Standout
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Guillain-Barré syndrome
2005 Standout
A dose of 75 μg/kg/d of i.v. anti‐D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura
2001
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.
1992
Ventilator-associated Pneumonia
2002 Standout
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
2007
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Inflammatory Muscle Diseases
2015 Standout
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
2001 Science
Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults
1984
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
2007
Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine
1991
Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.
1988
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
1983 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
The nontreatment of childhood idiopathic thrombocytopenic purpura
1987
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
1999 StandoutNobel
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura
1984
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
Side-effects of intravenous immune globulins.
1994
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
1985
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
2000
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [see comments]
1991
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
2008
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
HLA and Disease 1982 ‐ A Survey
1983
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
1996
Glycosyltransferases: Structures, Functions, and Mechanisms
2007 Standout
Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone Therapy
1994
Possible mechanisms for intravenous immunoglobulin–associated hemolysis: clues obtained from review of clinical case reports
2015
Cyanotic congenital heart disease: Hematologic management
1991
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: Comparative efficacy of 7S and 5S preparations
1986
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of A. Salama being referenced
IgG therapy in autoimmune haemolytic anaemia of warm type
1984
Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D))
1984
Complete subtyping of the HLA‐A locus by sequence‐specific amplification followed by direct sequencing or single‐strand conformation polymorphism analysis
1995
Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay
2001
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
2008
Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary Bypass
1988
Immunoadsorption patients with multiple sclerosis: an open‐label pilot study
2005
Drug-Induced Immune Cytopenias: A Unifying Pathogenetic Concept With Special Emphasis on the Role of Drug Metabolites
1990
Sequence analysis of the 2nd intron revealed common sequence motifs providing the means for a unique sequencing based typing protocol of the HLA‐A locus
1996
Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuria
1988
Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia
2006
Immune hemolysis-serological and clinical aspects
2003
A Two‐Stage Immunoradiometric Assay with 125I‐Staphylococcal Protein A for the Detection of Antibodies and Complement on Human Blood Cells1
1985
Effect of IgG anti‐Rho(D) in adult patients with chronic autoimmune thrombocytopenia
1986
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA
1983
6th International Immunoglobulin Symposium: Poster presentations
2009
Results of Treatment with Rituximab (Anti-CD20) in Three Patients with Autoimmune Hemolytic Anemia and/or Immune Thrombocytopenia and a Concise Review of Reported Cases
2002
Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto‐ and/or drug‐dependent antibodies against these cells
1987
HLA‐B7 on human red blood cells. Improved detection by a radioactive anti‐IgG test*
1982
Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)
1986
Präoperative Identifikation von Patienten mit (primären) Hämostasestörungen
2007
Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura
2009